KOTAKBANK: Q2 FRESH SLIPPAGES 12.3B RUPEES VS 16.3B (YOY); 13.2B (QOQ)

KOTAKBANK: Q2 PROVISIONS AND CONTINGENCIES 8B RUPEES VS 6.7B (QOQ)

KOTAKBANK: Q2 SL NET PROFIT 42.11B RUPEES VS 32.5B (YOY); Q2 REVENUE 159B RUPEES VS 136B (YOY) - CORRECT

KOTAKBANK: Q2 GNPA 1.04% VS 1.18% (QOQ); Q2 NNPA 0.24% VS 0.27% (QOQ)

KOTAKBANK: Q2 SL NET PROFIT 42.11B RUPEES VS 32.5B (YOY); Q2 REVENUE 199B RUPEES VS 172B (YOY) - CORRECT

KOTAKBANK: Q2 SL NET PROFIT 56B RUPEES VS 45B (YOY)

KOTAKBANK: Q2 REVENUE 199B RUPEES VS 172B (YOY)

Seamec: Co Vessel "Seamec Swordfish" Is Off-Hired Due To Technical Issues Starting October 24, 2026; Repairs Underway.

Tata Chemicals: HC Of Kenya Declares No Jurisdiction On Dispute Involving Tata Chemicals Magadi Limited; Co. To Examine Order And Take Necessary Legal Steps; Committee Undertaking Technical Review For Sustainable Mining Framework.

Dr. Reddy's: Lowers FY27 Capital Expenditure To ₹1,600–1,700 Crore From ₹1,800 Crore Because Of Project Timing Adjustments.

Dr. Reddy's: Semaglutide Relaunch Remains On Track For November 2026, With FY27 Volume Guidance Of 6 - 7 Million Pens Maintained.

Dr. Reddy's: Lab Maintains FY27 EBITDA Margin Forecast Above 20%, Reports Q2 Margins At 20.6%

Shriram Finance: Cuts FY27 AUM Growth Target To 15-17% From Previous 18%

KEC International: Co Secures ₹2,872 Crore Orders From PGCIL For 765 KV Transmission Lines Supporting 8.5 GW Renewable Energy Evacuation In Gujarat, The Largest Single Order In India’s T&D Sector.

RailTel Corp: Secures ₹20.04 Crore Deal With Munitions India For Data And Disaster Recovery Centers For Q-Shakti Project.

DigiSpice Tech: Spice Money Gets RBI Approval As Physical Payment Aggregator With Conditions.

IdeaForge Tech: Co's US Unit Ends Joint Venture Agreement With First Breach Inc. By Mutual Agreement Due To Missed Deadline.